Sign in

CIK 0001826457

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Monte Rosa Therapeutics, Inc.

Sign in to watch
Ticker
GLUE
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 617-949-2643
Business address
321 HARRISON AVENUE, SUITE 900, BOSTON, MA, 02118
Former names
Monte Rosa Therapeutics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$137
in 1 filing

Net −$137. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Bowen Matthew −$137 Principal Accounting Officer sold <1% of stake
Date Insider Transaction Shares Price Value Owned after
2022-03-01 Wallace Owen B. Chief Scientific Officer Grant or award · Stock Option (Right to Buy) +117,450 117,450
2022-03-01 Warmuth Markus President & CEO Grant or award · Stock Option (Right to Buy) +315,600 315,600
2021-06-28 Cormorant Asset Management, LP Former 10% Owner Conversion +2,602,200 2,602,200
2021-06-28 Cormorant Asset Management, LP Former 10% Owner Purchase +600,000 $19.00 $11.4M 3,202,200
2021-06-28 Cormorant Asset Management, LP Former 10% Owner Conversion · Series B Convertible Preferred Stock +2,124,343 0
2021-06-28 Cormorant Asset Management, LP Former 10% Owner Conversion · Series C Convertible Preferred Stock +477,857 0
2021-06-28 Yang Rick 10% owner Conversion +2,715,968 2,715,968
2021-06-28 Yang Rick 10% owner Conversion +3,257,328 5,973,296
2021-06-28 Yang Rick 10% owner Conversion +669,002 6,642,298
2021-06-28 Yang Rick 10% owner Purchase +1,050,000 $19.00 $19.9M 7,692,298
2021-06-28 Yang Rick 10% owner Conversion · Series A-2 convertible preferred stock −9,588,725 0
2021-06-28 Yang Rick 10% owner Conversion · Series B convertible preferred stock −11,500,000 0
2021-06-28 Yang Rick 10% owner Conversion · Series C convertible preferred Stock −2,361,912 0
2021-06-28 Walker Paul Edward 10% owner Conversion +2,715,968 2,715,968
2021-06-28 Walker Paul Edward 10% owner Conversion +3,257,328 5,973,296
2021-06-28 Walker Paul Edward 10% owner Conversion +669,002 6,642,298
2021-06-28 Walker Paul Edward 10% owner Purchase +1,050,000 $19.00 $19.9M 7,692,298
2021-06-28 Walker Paul Edward 10% owner Conversion · Series A-2 convertible preferred stock −9,588,725 0
2021-06-28 Walker Paul Edward 10% owner Conversion · Series B convertible preferred stock −11,500,000 0
2021-06-28 Walker Paul Edward 10% owner Conversion · Series C convertible preferred Stock −2,361,912 0

Page 10 of 16 · 310 trades